Moolec Science (MLEC) Non-Current Debt (2023 - 2025)
Moolec Science (MLEC) reported Non-Current Debt of $1.3 million for Q2 2025, down 98.94% on a YoY basis from $127.2 million in Q2 2024, and down 98.94% sequentially from $127.2 million in Q2 2024.
Moolec Science (MLEC) Non-Current Debt (2023 - 2025) Analysis & Trends
Moolec Science (MLEC) has 3 years of Non-Current Debt data on file, last reported at $1.3 million in Q2 2025.
- For the quarter ending Q2 2025, Non-Current Debt fell 98.94% year-over-year to $1.3 million; the trailing twelve-month figure through Jun 2025 stood at $1.3 million (down 98.94% YoY), and the FY2025 full-year result was $1.3 million, down 98.94% from the prior year.
- Non-Current Debt declined to $1.3 million in Q2 2025, from $127.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $127.2 million in Q2 2024 to a low of $1.2 million in Q1 2023.
- A 3-year average of $28.0 million and a median of $2.5 million in 2023 frame the typical range for Non-Current Debt.
- Across the five-year window, Non-Current Debt jumped 4897.49% in 2024 and sank 98.94% in 2025, its largest moves.
- Tracing MLEC's Non-Current Debt over 3 years: stood at $7.8 million in 2023, then jumped by 1521.87% to $127.2 million in 2024, then slumped by 98.94% to $1.3 million in 2025.
- Business Quant data shows MLEC's Non-Current Debt at $1.3 million in Q2 2025, $127.2 million in Q2 2024, and $7.8 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2024 | 127.25 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 1.18 Mn |